In this report, the United States Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Influenza Vaccine in these regions, from 2012 to 2022 (forecast).

United States Influenza Vaccine market competition by top manufacturers/players, with Influenza Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Influenza Vaccine for each application, including
Children
Adults
Elderly
Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Influenza Vaccine Market Report 2017
1 Influenza Vaccine Overview
1.1 Product Overview and Scope of Influenza Vaccine
1.2 Classification of Influenza Vaccine by Product Category
1.2.1 United States Influenza Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Influenza Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Trivalent Influenza Vaccine
1.2.4 Quadrivalent Influenza Vaccine
1.2.5 Other
1.3 United States Influenza Vaccine Market by Application/End Users
1.3.1 United States Influenza Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.3.5 Pregnancy
1.4 United States Influenza Vaccine Market by Region
1.4.1 United States Influenza Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Influenza Vaccine Status and Prospect (2012-2022)
1.4.3 Southwest Influenza Vaccine Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Influenza Vaccine Status and Prospect (2012-2022)
1.4.5 New England Influenza Vaccine Status and Prospect (2012-2022)
1.4.6 The South Influenza Vaccine Status and Prospect (2012-2022)
1.4.7 The Midwest Influenza Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Influenza Vaccine (2012-2022)
1.5.1 United States Influenza Vaccine Sales and Growth Rate (2012-2022)
1.5.2 United States Influenza Vaccine Revenue and Growth Rate (2012-2022)

2 United States Influenza Vaccine Market Competition by Players/Suppliers
2.1 United States Influenza Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Influenza Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Influenza Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Influenza Vaccine Market Competitive Situation and Trends
2.4.1 United States Influenza Vaccine Market Concentration Rate
2.4.2 United States Influenza Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Influenza Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Influenza Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Influenza Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Influenza Vaccine Price by Region (2012-2017)

4 United States Influenza Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Influenza Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Influenza Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Influenza Vaccine Price by Type (2012-2017)
4.4 United States Influenza Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Influenza Vaccine Sales (Volume) by Application (2012-2017)
5.1 United States Influenza Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Influenza Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Influenza Vaccine Players/Suppliers Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Influenza Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sinovac
6.2.2 Influenza Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Changsheng
6.3.2 Influenza Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Changsheng Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 CCBIO
6.4.2 Influenza Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 CCBIO Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
6.5.2 Influenza Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Aleph Biomedical Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.2 Influenza Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
6.7.2 Influenza Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Siobp
6.8.2 Influenza Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Siobp Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Hualan Bio
6.9.2 Influenza Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
6.10.2 Influenza Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Tianyuan Bio-Pharma Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan

7 Influenza Vaccine Manufacturing Cost Analysis
7.1 Influenza Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Influenza Vaccine Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Influenza Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Influenza Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Influenza Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Influenza Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer




List of Tables and Figures

Figure Product Picture of Influenza Vaccine
Figure United States Influenza Vaccine Market Size (K Doses) by Type (2012-2022)
Figure United States Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure United States Influenza Vaccine Market Size (K Doses) by Application (2012-2022)
Figure United States Sales Market Share of Influenza Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure United States Influenza Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2022)
Figure United States Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table United States Influenza Vaccine Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table United States Influenza Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Influenza Vaccine Sales Share by Players/Suppliers
Figure United States Influenza Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Influenza Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Influenza Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Influenza Vaccine Revenue Share by Players/Suppliers
Table United States Market Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2012-2017)
Figure United States Market Influenza Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2016
Figure United States Influenza Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Influenza Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Influenza Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Influenza Vaccine Product Category
Table United States Influenza Vaccine Sales (K Doses) by Region (2012-2017)
Table United States Influenza Vaccine Sales Share by Region (2012-2017)
Figure United States Influenza Vaccine Sales Share by Region (2012-2017)
Figure United States Influenza Vaccine Sales Market Share by Region in 2016
Table United States Influenza Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Influenza Vaccine Revenue Share by Region (2012-2017)
Figure United States Influenza Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Influenza Vaccine Revenue Market Share by Region in 2016
Table United States Influenza Vaccine Price (USD/Dose) by Region (2012-2017)
Table United States Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table United States Influenza Vaccine Sales Share by Type (2012-2017)
Figure United States Influenza Vaccine Sales Share by Type (2012-2017)
Figure United States Influenza Vaccine Sales Market Share by Type in 2016
Table United States Influenza Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Influenza Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Type (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Type in 2016
Table United States Influenza Vaccine Price (USD/Dose) by Types (2012-2017)
Figure United States Influenza Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table United States Influenza Vaccine Sales Market Share by Application (2012-2017)
Figure United States Influenza Vaccine Sales Market Share by Application (2012-2017)
Figure United States Influenza Vaccine Sales Market Share by Application in 2016
Table United States Influenza Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Influenza Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Influenza Vaccine Sales Growth Rate (2012-2017)
Figure GSK Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Sinovac Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sinovac Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Sinovac Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Sinovac Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Changsheng Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changsheng Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Changsheng Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Changsheng Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table CCBIO Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CCBIO Influenza Vaccine Sales Growth Rate (2012-2017)
Figure CCBIO Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure CCBIO Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Aleph Biomedical Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Lanzhou Institute Of Biological Product Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Siobp Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Siobp Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Siobp Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Siobp Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Hualan Bio Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Hualan Bio Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Tianyuan Bio-Pharma Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Growth Rate (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share in United States (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share in United States (2012-2017)
Table Vaxtec Basic Information List
Table Hissen Basic Information List
Table Abbott Basic Information List
Table Novartis Basic Information List
Table Tasly&Jenner Basic Information List
Table Tiantan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure United States Influenza Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Vaccine Price (USD/Dose) Trend Forecast (2017-2022)
Table United States Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Influenza Vaccine Sales Volume (K Doses) Forecast by Type (2017-2022)
Figure United States Influenza Vaccine Sales Volume (K Doses) Forecast by Type in 2022
Table United States Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Influenza Vaccine Sales Volume (K Doses) Forecast by Application (2017-2022)
Figure United States Influenza Vaccine Sales Volume (K Doses) Forecast by Application in 2022
Table United States Influenza Vaccine Sales Volume (K Doses) Forecast by Region (2017-2022)
Table United States Influenza Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Rapid Influenza Diagnostic Test (RIDT) Industry Status and Prospects Professional Market Research Report Standard Version...

The global Rapid Influenza Diagnostic Test (RIDT) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...